Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

1902 - Evaluation of Quality of Life in survivors with malignant pleural mesothelioma in Japan


09 Sep 2017


Poster display session




Isao Oze


Annals of Oncology (2017) 28 (suppl_5): v568-v572. 10.1093/annonc/mdx389


I. Oze1, Y. Nagamatsu2, K. Aoe3, K. Hotta4, K. Kato5, J. Nakagawa6, K. Hara6, T. Kishimoto7, N. Fujimoto8

Author affiliations

  • 1 Division Of Molecular And Clinical Epidemiology, Aichi Cancer Center Research Institute, 464-8681 - Nagoya/JP
  • 2 College Of Nursing, St. Luke’s International University, Tokyo/JP
  • 3 Department Of Medical Oncology, National Hospital Organization Yamaguchi-Ube Medical Center, Ube/JP
  • 4 Center For Innovative Clinical Medicine, Okayama University Hospital, Okayama/JP
  • 5 Department Of Radiology, Kawasaki General Medical Center, Okayama/JP
  • 6 Department Of Nursing, Okayama Rosai Hospital, Okayama/JP
  • 7 Department Of Medicine, Okayama Rosai Hospital, Okayama/JP
  • 8 Department Of Medical Oncology, Okayama Rosai Hospital, Okayama/JP


Abstract 1902


Malignant pleural mesothelioma (MPM) is the malignancy with poor prognosis. Most patients with MPM present severe symptoms such as pain, dyspnea and fatigue. Because of the symptoms and poor prognosis, MPM survivors would have poor Quality of Life (QOL), however, their QOL has not been well evaluated.


Subjects were the survivors of MPM. We asked the cancer hospitals in Japan and MPM Patients' Association to distribute the self-administered questionnaire. QOL was evaluated using scales of the EORTC QLQ-C30 and QoQoLo short version. In addition to the QOL, clinical factors were collected using the questionnaire. Mean and its standard deviation were used to evaluate QOL scores. Wilcoxon rank sum test was used to compare the QOL scores. Factors affecting the QOL score were evaluated by multiple regression model.


In total, 133 survivors with MPM participated in the study. Regarding the QOL evaluated by QLQ-C30: functional scales were poor (scores >50), while symptom scales were not so poor (scores 2 years from diagnosis, and female. Similarly, good PS and >2 years from diagnosis were the factors caused higher total score of CoQoLo core domein.


Survivors with MPM had physical and psychological difficulties. Even the survivors with good PS had functional difficulty. Individualized supports are required for survivors with MPM.

Clinical trial identification

Legal entity responsible for the study

Nobukazu Fujimoto


Ministry of Health, Labour and Welfare, Japan


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.